We have also shown that in vivo corticosteroids selectively (leplete functionial subpopulatioins of 1vmphlocvtes as measured by proliferation to mitogens (2, 7). WN'e suggested at that time that in adlditioni to selectivelv affecting T cells more than B cells, corticosteroids probably also had a selective effect on stubsets withini the T-cell class, since we found that 4 h after in vivo administration of 400 mig of hydrocortisone, the blastogenic response of peripheral blood lymphocytes to phvtohemagglutinin was unchanged, while the responise to conicanavalin A was markedly reduced (2) .
Recently, Moretta and his colleagues have delineated distinct subpopulations of human T lymphocytes based on the presence or absence of cell surface receptors for the Fe portioni of IgG (T-G cells) or IgM (T.M cells) (8) (9) (10) . They have further shown in a system employing pokeweed mitogen-stimulated B-cell production of intracytoplasmic antibody that the T.M cells are the T "helper" cells and the T.(,, cells are the T "suppressor" cells (11) .
The present study was undertaken to determine the differential effects of in vivo administration hydrocortisonie on the kinetics of these distinct subpopulations of T cells in normal subjects. In order to rule out the possibility that hydrocortisone binding to T lymphocytes might interfere with T.M or T.G rosette formation, conitrol experiments were performed in which T cells were exposed to hydrocortisone in vitro before rosetting for T.M or T.G markers. Purified T cells were incubated for 1 h at 37°C in media or with either 0.1 mM, 10 ,uM, or 1 ,uM hydrocortisone and washed three times in TC 199 media; and rosette determinations for T.G or T.M were performed as described above.
RESULTS
Base-line values for lymphocyte subpopulations in normal subjects. In the present study, 86±+-3% of peripheral blood lymphocytes were found to be sheep erythrocyte-rosette positive (T cells) and 14±+3% were found to be non-T lymphocytes ( Effect of in vivo hydrocortisone on the kinetics of T-cell subpopulations. As shown previously, in vivo hydrocortisone administration to normal subjects produced a profound lymphopenia (from 2,206±+147 to 845+136 lymphocytes/mm3) maximal at 4 h after drug administration which selectively affected T cells as compared to non-T cells (2, 3) . 24 h after hydrocortisone administration there was a slight rebound lymphocytosis which returned to normal at 48 h (2) . In contrast to the T-cell fraction of lymphocytes, the absolute number of non-T cells (B cells plus other non-T cells) did not decrease but remained essentially the same (P > 0.2). At 4 h after hydrocortisone administration, the percent of T.G cells in the total T-cell population rose significantly (P < 0.001), while the percent of T.M cells fell (P < 0.01). The percent of T.nOn-M, non-G cells followed the pattern of the T,M cells and also decreased (P < 0.05) (Fig. 1) . At 24 h, there was a slight rebound increase in T.M cells which was not significantly different from the 0-h value, and a slight but nonsignificant decrease in T.G. By 48 h after hydrocortisone, all values had returned to base line.
When absolute numbers of lymphocytes in the T-cell subpopulations were calculated (Fig. 2) , it was found that at 4 h after hydrocortisone administration, the numbers of T.M cells markedly decreased (P < 0.001).
In addition, the number of Tnon-M, non-G cells significantly decreased (P < 0.02), while the absolute number of T.G cells were essentially unchanged (P > 0.2). At 24 h, there was a rebound increase in the numbers of T., Thtus, the data show that 4 In ain elegant series of papers, Moretta anid his colleagues have described the T.M sulbset of human T lymphocytes which comiiprise approximately 55-7.5% of humiicani T cells aild which bind the Fe portion of the pentamiieric formii of IgM (8, 13) . Other laboratories have now confirmiied these finidings in human T cells (14) and, as well, have demonstratedl T.M cells in m1o1Use T-cell sUspen1sion1s (15) .
T cells beariing receptors for IgG have been previouslv showni to exist in humilcanis 1b several laboratories (9, 16, 17) . Moretta activation with immune complexes, are the "suppressor" T lymphocytes (11) . Furthermore, T.M and T.G cells are also functionally separable on the basis of differential blast transformation to phytohemagglutinin, in that T.M cells respond well to phytohemagglutinin while T.G cells do not (10) . Thus, the initial observations of Moretta et al. suggest that T.M and T.G are distinct subsets of' human T cells and may in some ways be analogous to the Ly 1 (helper) and Ly 2,3 (suppressor) T-cell subsets defined in the mouse (18) .
The selective effect of in vivo hydrocortisone on T-versus B-cell kinetics is now well established (2-4). Our previous findings (5, 6) using labeled autologous lymphocytes which showed that hydrocortisone causes a redistribution of predominately recirculating T lymphocytes out of the circulation (most likely to the bone marrow compartment and possibly to the spleen) can now be further refined. hydrocortisone administration to normal subjects was also noted by us together with a concomitant increase in antibodydependent cellular cytotoxicity 4 h after hydrocortisone administration (19) . However, these observations (4, 19) were made on unfractionated mononuclear cell suspensions in which IgG Fc receptors are found on monocytes, B cells, null cells, and as just recently recognized, on a small fraction of T cells (9) .
In contradistinction, the present study describes the selective and differential effects of corticosteroids on subpopulations of purified T cells recognized by surface markers which until recently were not described (8) (9) (10) (20, 21) . Because of their anti-inflammmatory acnd immunosuppressive properities aind their efficacy in controlling the inflammatory manifestations of disease (1), corticosteroids have long been used as the primary mode of therapy in autoimmune disease. It is possible that the selective depletion of a helper T-cell subpopulation by in vivo corticosteroids with the resulting relative increase in proportion of the suppressor T-cell subpopulation contribtutes to the therapeutic effect of this drug in (liseases associated with lack of suppressive immunoregtulatory control. It is obvious that much more information is needed to completely define the full range of ftunctional capabilities of these various lymphocyte subpopulations before a full understanding of the mechanisms of corticosteroidmediated immune regulation is to be achieved. Hopefully, the present observation of the selective and differential lymphopenic effect of in vivo hydrocortisone on identifiable and distinct T-cell subsets will help provide insight into the mechanisms of immunoregulation by corticosteroids. In this regard, it may be possible to define a degree of specificity in these agents which for so long have been characterized by the nonspecificity of their therapeutic effect.
